Related Experiment Video
Updated: Jun 19, 2026
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and Therapy
Ab Majeed Ganai1, Eirinaios I Vrettos1, Stavroula G Kyrkou1
1Department of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece.
Abstract:
Kinase inhibitors are potent therapeutic agents in cancer treatment, but their effectiveness is frequently restricted by the inability to image the tumor microenvironment. To address this constraint, kinase inhibitor-fluorophore conjugates have emerged as promising theranostic agents, allowing for simultaneous cancer diagnosis and treatment. These conjugates are gaining attention for their ability to visualize malignant tissues and concurrently enhance therapeutic interventions. This review explores the design principles governing the development of multimodal inhibitors, highlighting their potential as platforms for kinase tracking and inhibition via bioimaging. The structural aspects of constructing such theranostic agents are critically analyzed. This work could shed light on this intriguing field and provide adequate impetus for developing novel theranostic compounds based on small molecule inhibitors and fluorophores.
Insights
Kinase inhibitor-fluorophore conjugates offer simultaneous cancer diagnosis and treatment by enabling tumor microenvironment imaging. This theranostic approach enhances therapeutic interventions and visualizes malignant tissues effectively.
Area of Science:
- Oncology
- Biomedical Engineering
- Pharmacology
Background:
- Kinase inhibitors are vital cancer therapeutics.
- Imaging the tumor microenvironment is a key challenge.
- Current limitations hinder effective cancer treatment monitoring.
Purpose of the Study:
- To review the design principles of multimodal kinase inhibitors.
- To highlight their potential in kinase tracking and inhibition via bioimaging.
- To analyze structural aspects of developing theranostic agents.
Main Methods:
- Literature review of kinase inhibitor-fluorophore conjugates.
- Analysis of design principles for multimodal inhibitors.
- Critical examination of structural aspects for theranostic agent construction.
Main Results:
- Kinase inhibitor-fluorophore conjugates enable simultaneous diagnosis and treatment.
- These agents visualize malignant tissues and enhance therapeutic interventions.
- Multimodal inhibitors show promise for kinase tracking and inhibition.
Conclusions:
- Kinase inhibitor-fluorophore conjugates are promising theranostic agents.
- Further development of these compounds can advance cancer therapy.
- This review provides impetus for novel theranostic compound development.
